Regional Distribution Hubs for HIV/AIDS Drug Supply in Africa: A Cost-Benefit Analysis by Vargas, Ania
MIT	Global	Scale	Network	
MIT SCALE RESEARCH REPORT 
The MIT Global Supply Chain and Logistics Excellence 
(SCALE) Network is an international alliance of 
leading-edge research and education centers, dedicated 
to the development and dissemination of global 
innovation in supply chain and logistics. 
The Global SCALE Network allows faculty, researchers, 
students, and affiliated companies from all six centers 
around the world to pool their expertise and collaborate 
on projects that will create supply chain and logistics 
innovations with global applications. 
This reprint is intended to communicate research results 
of innovative supply chain research completed by 
faculty, researchers, and students of the Global SCALE 
Network, thereby contributing to the greater public 
knowledge about supply chains.  
For more information, contact 
MIT Global SCALE Network 
Postal Address:  
Massachusetts Institute of Technology 77 
Massachusetts Avenue, Cambridge, MA 02139 (USA) 
Location:  
Building E40, Room 267 
1 Amherst St.  
Access:  
Tel: +1 617-253-5320 
Fax: +1 617-253-4560 
Email: scale@mit.edu 
Website: scale.mit.edu 
Research Report: ZLC-2009-17
Regional Distribution Hubs for HIV/AIDS Drug Supply in Africa: A Cost-Benefit Analysis
Ania Vargas Muñoz
MIT	Global	Scale	Network	
For Full Thesis Version Please Contact: 
Marta Romero 
ZLOG Director 
Zaragoza Logistics Center (ZLC) Edificio 
Náyade 5, C/Bari 55 – PLAZA 50197 
Zaragoza, SPAIN  
Email: mromero@zlc.edu.es 
Telephone: +34 976 077 605 
   
Executive Summary, MIT-Zaragoza Master’s Thesis, 2009 1 
________________________________________________________ 
Regional Distribution Hubs for HIV/AIDS Drug Supply in Africa: 
A Cost-Benefit Analysis 
Ania Vargas Muñoz 
EXECUTIVE SUMMARY 
_______________________________________________________ 
 
There are about 9.7 million people in the world in need of antiretroviral (ARV) treatment for 
HIV/AIDS. Less than 3 million of them had access to it at the end of 2007, despite continued 
efforts of the global HIV/AIDS healthcare community. Africa is the region of the world most 
affected by the HIV/AIDS pandemic, with the Sub-Saharan Africa representing 67% of 
people living with HIV infection and 72% of AIDS deaths in 2007. One of the main causes of 
this dire situation is the lack of an effective and efficient antiretroviral supply chain. 
Historically, viral infections and HIV/AIDS prevention, care, and treatment programs in 
Africa relied on intermittent direct shipments of bulky quantities of ARVs, HIV test kits, and 
other indispensable provisions, frequently enough to supply more than six months of demand 
consumption. By pre-positioning strategic stock of these items regionally, and by moving 
smaller, and more frequent shipments to consumer countries, programs such as those 
developed by the Supply Chain Management System (SCMS), have ensured a rapid response 
to HIV/AIDS program needs. 
This thesis focused on investigating the economic and operational impacts of using a regional 
distribution center for HIV/AIDS drug supply in Africa, rather than relying on intermittent 
direct shipments of bulky quantities of ARVs. Using SCMS’s Regional Distribution Center 
(RDC) located in Centurion, South Africa, as a case study, total operational cost and 
quantifiable benefits of utilizing a distribution hub for HIV/AIDS drug supply in Africa were 
identified. 
 
The main performance measures addressed in this study are the response time, the total cost 
of operations, and service level: 
• Response time: Defined as the time from the point the client countries place an order 
until the time the order is received, response time diminution contributes to reducing 
inventory investment requirements, supports the development of agile operations, and 
reduces the probability of spoilage and product expiration while in transit. 
• Total cost of operations: Defined as the sum of the transportation and inventory 
related costs, the main difference between intermittent direct shipments and an RDC 
approach relies on the different proportions of ocean, air, and truck shipments and 
consequent safety stock requirements. 
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• Service level: Measured as the percentage of on-time delivery, this allows for the 
development of responsive operations needed to support delivery activities in many 
countries where the lack of access to treatment constitutes a matter of life or death. 
This thesis demonstrated that as the service level offered to end-customers approaches 100%, 
the difference in the average inventory held in a system with RDCs or with direct shipments to 
countries becomes larger, with much lower inventory required in the system with RDCs. In 
addition, the potential reduction in response time in a system with RDCs depends on the Cycle 
Service Level maintained, since the time to fulfill an order placed by regional countries is 
mainly given by the inventory availability at the RDC. Finally, there are observable potential 
savings related to transportation cost that could further reduce the extent of the additional cost. 
Clearly, there are economic and operational benefits of utilizing regional distribution hubs for 
HIV/AIDS drug supply in Africa. Using PEPFAR’s Regional Distribution Center in South 
Africa as an example, we showed that the use of RDCs leads to:  
 
• Consistent cost advantages in regard to the system’s inventory requirements. 
• Shorter response time since the lead-time assumes shorter values than those 
obtained through a direct shipment model. 
• Reduced transportation costs and reduced overall system uncertainty. 
 
By implementing activities oriented toward reducing transportation-related costs and overall 
system uncertainty and by expanding the usage of RDCs for the delivery of additional 
medications and related commodities - such as Malaria drugs - there are many opportunities 
to improve operational processes in drug distribution. However, the viability of increasing the 
utilization of such regional distribution centers for other supplemental drugs raises questions 
like who will sustain the cost of holding such levels of pre-positioned inventory in the long 
run. In spite of such considerations, RDCs offer an effective and efficient way to improve the 
ARV supply chain and assuage the HIV/AIDS pandemic in Sub-Saharan Africa. 
